NERVE GROWTH FACTOR * MEASUREMENT METHOD VALIDATION STUDY: DRIED BLOOD SPOT ANALYSIS AND SALIVA SAMPLE TESTING COMPARED TO VENOUS SERUM CONCENTRATION

NERVE GROWTH FACTOR * MEASUREMENT METHOD VALIDATION STUDY: DRIED BLOOD SPOT ANALYSIS AND SALIVA SAMPLE TESTING COMPARED TO VENOUS SERUM CONCENTRATION - NGF * validation study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON44502

Enrollment

Registered

2018-01-15

Start date

2017-12-20

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

valideren van diagnostische testen nerve growth factor nerve growth factor

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy female and male participants, 18 years or older, who are willing to give informed consent, have sufficient command of Dutch or English language and are capable of understanding participants information.

Exclusion criteria

Exclusion criteria: - Contraindications for donating blood (phlebitis, dermatitis, psoriasis, lymphedema, arterial venous fistula, hematoma on or around insert place, mamma-amputation or axillary dissection of lymph nodes) - Poor dental condition - Age

Design outcomes

Primary

Measure	Time frame
The main study parameters are the correlation and limits of agreement between dried blood spots/saliva samples compared to venous blood concentration.	—

Countries

Netherlands

Outcome results